HIQPHARM
Index Performance
+1.62%
HIQPHARM
+4.60%
TMLARGE
+4.45%
SPY
+1.34%
DIA
Overview
Description
Pharma
- TickerHIQPHARM
- Inception Date12/04/2023
- WeightingSq. Root Market Cap
- # of holdings127
What's inside?
Holdings
All holdings as of May 3, 2024
CSV download
| Eli Lilly & Co. (LLY) | 4.52% | $698.52B | 25.98% | 80.91% | 20.23 |
| Novo Nordisk A/S (NOVO.B) | 3.64% | $411.61B | 22.45% | 84.83% | 16.20 |
| Johnson & Johnson (JNJ) | 3.32% | $359.25B | -13.55% | 68.78% | 4.37 |
| Merck & Co., Inc. (MRK) | 3.30% | $322.94B | 8.38% | 75.11% | 5.96 |
| AstraZeneca PLC (AZN) | 3.03% | $234.62B | 11.68% | 75.21% | 4.95 |
| AbbVie, Inc. (ABBV) | 2.93% | $290.01B | 0.70% | 66.84% | 6.96 |
| Novartis AG (NOVN) | 2.55% | $191.90B | -13.70% | 73.54% | 4.53 |
| Roche Holding AG (RO) | 2.51% | $193.71B | -7.21% | 73.06% | 3.99 |
| Amgen, Inc. (AMGN) | 2.46% | $166.83B | 22.19% | 56.73% | 7.04 |
| Pfizer Inc. (PFE) | 2.34% | $157.04B | -18.61% | 77.29% | N/A |
| Sanofi (SAN) | 2.01% | $123.41B | 0.17% | 61.52% | 2.85 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 1.81% | $103.71B | -0.54% | 82.58% | 7.86 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 1.78% | $103.60B | 12.47% | 87.17% | 9.71 |
| GSK Plc (GSK) | 1.73% | $88.79B | 5.93% | 73.69% | 2.71 |
| Bristol Myers Squibb Co. (BMY) | 1.58% | $89.17B | 4.66% | 55.54% | 3.46 |
| Daiichi Sankyo Co., Ltd. (4568) | 1.57% | $68.85B | 25.28% | 74.07% | 5.38 |
| Zoetis, Inc. (ZTS) | 1.48% | $76.23B | 9.50% | 68.95% | 9.44 |
| McKesson Corp. (MCK) | 1.47% | $69.50B | 14.77% | 3.75% | 0.22 |
| CVS Health Corp. (CVS) | 1.31% | $70.18B | 3.60% | 14.22% | 0.47 |
| Lonza Group AG (LONN) | 1.21% | $42.51B | 7.94% | 27.04% | 4.11 |
| Chugai Pharmaceutical Co., Ltd. (4519) | 1.17% | $54.68B | -24.11% | 69.21% | 8.44 |
| Cencora, Inc. (ABC) | 1.16% | $44.67B | 7.81% | 3.30% | 0.19 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) | 1.14% | $40.53B | 9.15% | 84.13% | 11.74 |
| Haleon Plc (HLN) | 1.12% | $37.84B | 4.09% | 61.13% | 3.39 |
| Takeda Pharmaceutical Co., Ltd. (4502) | 1.12% | $42.36B | 1.33% | 53.81% | 2.59 |
| Biogen, Inc. (BIIB) | 0.99% | $31.67B | -5.62% | 68.65% | 4.02 |
| Bayer AG (BAYN) | 0.97% | $29.58B | -6.11% | 58.54% | 1.41 |
| UCB SA (UCB) | 0.94% | $24.48B | -4.80% | 63.63% | 3.33 |
| Novozymes A/S (NZYM.B) | 0.89% | $16.47B | 1.97% | 52.03% | 6.15 |
| Otsuka Holdings Co., Ltd. (4578) | 0.87% | $22.60B | 15.87% | 70.78% | 1.56 |
| Cardinal Health, Inc. (CAH) | 0.82% | $24.09B | 8.76% | 3.43% | 0.13 |
| Merck KGaA (MRK) | 0.81% | $21.11B | -5.57% | 55.59% | 3.36 |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) | 0.81% | $19.78B | 20.79% | 46.86% | 13.07 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 0.79% | $19.27B | 54.82% | 86.65% | 9.57 |
| BeiGene Ltd. (688235) | 0.77% | $17.68B | 82.71% | 81.13% | 9.91 |
| Sartorius Stedim Biotech SA (DIM) | 0.76% | $21.78B | -6.86% | N/A | N/A |
| Astellas Pharma, Inc. (4503) | 0.73% | $18.32B | 5.60% | 75.60% | 2.21 |
| Avantor, Inc. (AVTR) | 0.72% | $16.79B | -5.65% | 33.96% | 3.28 |
| Hansoh Pharmaceutical Group Co., Ltd. (3692) | 0.72% | $13.85B | 2.33% | 89.80% | 6.47 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 0.71% | $15.60B | 6.26% | 48.26% | 1.85 |
| Sartorius AG (SRT) | 0.70% | $18.64B | -9.26% | 48.34% | 7.25 |
| Sandoz Group AG (SDZ) | 0.70% | $13.67B | 0.74% | N/A | N/A |
| Yunnan Baiyao Group Co., Ltd. (000538) | 0.69% | $13.33B | 2.43% | 29.62% | 1.98 |
| Neurocrine Biosciences, Inc. (NBIX) | 0.68% | $14.16B | 22.57% | 97.52% | 6.87 |
| BioMarin Pharmaceutical, Inc. (BMRN) | 0.68% | $15.65B | 9.34% | 78.49% | 7.05 |
| United Therapeutics Corp. (UTHR) | 0.67% | $11.64B | 33.70% | 89.24% | 3.73 |
| Walgreens Boots Alliance, Inc. (WBA) | 0.67% | $15.36B | 6.28% | 17.35% | 0.37 |
| Sarepta Therapeutics, Inc. (SRPT) | 0.67% | $12.63B | 63.10% | 85.66% | 9.14 |
| Viatris, Inc. (VTRS) | 0.66% | $14.03B | -4.90% | 42.70% | 1.97 |
| Shionogi & Co., Ltd. (4507) | 0.65% | $13.73B | -43.34% | 85.50% | 4.02 |
| Eisai Co., Ltd. (4523) | 0.63% | $12.25B | -5.26% | 78.12% | 2.57 |
| Royalty Pharma Plc (RPRX) | 0.63% | $12.81B | 5.24% | N/A | 11.10 |
| CSPC Pharmaceutical Group Ltd. (1093) | 0.61% | $10.29B | -3.40% | 70.51% | 2.15 |
| WuXi AppTec Co., Ltd. (603259) | 0.60% | $16.96B | 2.27% | 39.99% | 5.18 |
| Ipsen SA (IPN) | 0.59% | $10.18B | 3.39% | 75.10% | 2.86 |
| Recordati SpA (REC) | 0.59% | $11.25B | 12.36% | 68.32% | 5.67 |
| Incyte Corp. (INCY) | 0.58% | $12.07B | 8.93% | 91.24% | 2.42 |
| Catalent, Inc. (CTLT) | 0.57% | $10.23B | -10.88% | 16.70% | 3.15 |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) | 0.53% | $8.19B | 14.83% | 52.94% | 2.01 |
| Innovent Biologics, Inc. (1801) | 0.50% | $8.49B | 29.43% | 81.69% | 8.54 |
| Huadong Medicine Co., Ltd. (000963) | 0.50% | $7.97B | 2.91% | 31.66% | 1.34 |
| Beijing Tong RenTang Co., Ltd. (600085) | 0.50% | $8.02B | 2.49% | 42.48% | 3.13 |
| CSPC Innovation Pharmaceutical Co., Ltd. (300765) | 0.49% | $6.65B | -23.78% | 45.79% | 18.05 |
| Ascendis Pharma A/S (ASND) | 0.49% | $7.92B | 436.15% | 78.07% | 25.52 |
| Intra-Cellular Therapies, Inc. (ITCI) | 0.48% | $7.26B | 85.51% | 92.73% | 13.75 |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (600332) | 0.48% | $6.83B | 6.12% | 21.79% | 0.61 |
| Dong-E-E-Jiao Co., Ltd. (000423) | 0.47% | $6.02B | 36.36% | 71.41% | 6.12 |
| Grifols SA (GRF) | 0.47% | $5.71B | 8.71% | 35.24% | 3.37 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) | 0.47% | $7.82B | -6.84% | 49.55% | 2.31 |
| Ono Pharmaceutical Co., Ltd. (4528) | 0.46% | $7.07B | 7.25% | 76.60% | 2.16 |
| Jazz Pharmaceuticals Plc (JAZZ) | 0.45% | $6.93B | 1.03% | 72.15% | 2.99 |
| Sichuan Kelun Pharmaceutical Co., Ltd. (002422) | 0.45% | $6.13B | 11.15% | 55.38% | 2.27 |
| Hangzhou Tigermed Consulting Co., Ltd. (300347) | 0.44% | $5.12B | -8.08% | 37.54% | 6.38 |
| Sino Biopharmaceutical Ltd. (1177) | 0.44% | $6.87B | -13.50% | 80.95% | 2.52 |
| Changchun High-Tech Industry (Group) Co., Ltd. (000661) | 0.43% | $6.32B | 14.51% | 83.30% | 3.06 |
| Organon & Co. (OGN) | 0.43% | $5.01B | 5.46% | 59.00% | 2.05 |
| Orion Oyj (ORNBV) | 0.42% | $5.45B | 10.25% | 55.33% | 3.98 |
| Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) | 0.42% | $5.24B | 0.49% | 80.81% | 2.48 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) | 0.41% | $4.88B | 23.01% | 71.07% | 8.58 |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223) | 0.40% | $4.94B | -17.40% | 49.43% | 3.80 |
| SK Biopharmaceuticals Co., Ltd. (326030) | 0.39% | $4.98B | 44.16% | 86.89% | 22.08 |
| Jointown Pharmaceutical Group Co., Ltd. (600998) | 0.38% | $4.43B | -3.86% | 6.96% | 0.43 |
| BridgeBio Pharma, Inc. (BBIO) | 0.38% | $5.21B | 11,461.88% | 99.10% | 30.87 |
| Wuxi Biologics (Cayman), Inc. (2269) | 0.38% | $7.61B | 6.01% | 40.08% | 6.66 |
| Livzon Pharmaceutical Group, Inc. (000513) | 0.37% | $4.50B | -4.80% | 64.32% | 2.32 |
| PT Kalbe Farma Tbk (KLBF) | 0.36% | $4.35B | 6.28% | 38.49% | 2.15 |
| Humanwell Healthcare (Group) Co., Ltd. (600079) | 0.36% | $4.50B | 2.27% | 45.97% | 1.64 |
| Hualan Biological Engineering, Inc. (002007) | 0.36% | $4.23B | -10.41% | 55.20% | 6.85 |
| H. Lundbeck A/S (HLUN.B) | 0.36% | $3.83B | 9.13% | 76.89% | 1.60 |
| China National Medicines Co., Ltd. (600511) | 0.35% | $3.62B | 7.96% | 6.82% | 0.40 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) | 0.35% | $3.35B | 21.45% | 59.26% | 2.84 |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603) | 0.34% | $4.35B | -36.27% | 50.61% | 3.94 |
| Axsome Therapeutics, Inc. (AXSM) | 0.34% | $3.54B | 440.80% | 87.84% | 12.62 |
| Fortrea Holdings, Inc. (FTRE) | 0.33% | $3.34B | 0.42% | 13.64% | 1.50 |
| Hypera SA (HYPE3) | 0.32% | $3.74B | 7.56% | 58.74% | 3.56 |
| Prestige Consumer Healthcare, Inc. (PBH) | 0.32% | $3.48B | 2.62% | 53.87% | 3.72 |
| Shanghai Junshi Biosciences Co., Ltd. (688180) | 0.32% | $3.54B | 49.13% | 71.19% | 15.80 |
| Pharmaron Beijing Co., Ltd. (300759) | 0.31% | $4.26B | -2.43% | 31.90% | 3.51 |
| Springworks Therapeutics, Inc. (SWTX) | 0.31% | $3.34B | N/A | 90.81% | 121.00 |
| Joincare Pharmaceutical Group Industry Co., Ltd. (600380) | 0.31% | $3.11B | -4.69% | 63.00% | 1.31 |
| Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. (603707) | 0.31% | $3.05B | -22.68% | 38.25% | 5.21 |
| Sinopharm Group Co., Ltd. (1099) | 0.31% | $3.36B | 2.67% | 7.83% | 0.23 |
| Asymchem Laboratories (Tianjin) Co., Ltd. (002821) | 0.30% | $4.09B | -39.35% | 41.82% | 3.35 |
| PTC Therapeutics, Inc. (PTCT) | 0.30% | $2.53B | -4.66% | 68.46% | 1.90 |
| China Traditional Chinese Medicine Holdings Co. Ltd. (570) | 0.30% | $2.77B | 20.38% | 51.18% | 1.20 |
| Redcare Pharmacy NV (SAE) | 0.29% | $2.82B | 50.57% | 20.45% | 1.56 |
| Twist Bioscience Corp. (TWST) | 0.29% | $2.40B | 25.13% | 41.01% | 6.41 |
| 3SBio, Inc. (1530) | 0.29% | $2.12B | 8.27% | 84.98% | 2.27 |
| Tonghua Dongbao Pharmaceutical Co., Ltd. (600867) | 0.29% | $2.71B | -11.15% | 78.55% | 6.47 |
| Chongqing Taiji Industry (Group) Co., Ltd. (600129) | 0.28% | $2.79B | -4.87% | 45.93% | 1.43 |
| Bausch Health Cos., Inc. (BHC) | 0.28% | $2.87B | 10.75% | 57.55% | 2.92 |
| Amicus Therapeutics, Inc. (FOLD) | 0.27% | $3.08B | 21.30% | 88.68% | 10.89 |
| Apeloa Pharmaceutical Co., Ltd. (000739) | 0.27% | $2.30B | 8.61% | 23.92% | 1.56 |
| Shandong Buchang Pharmaceuticals Co., Ltd. (603858) | 0.27% | $2.43B | -24.81% | 58.02% | 1.71 |
| Patterson Cos., Inc. (PDCO) | 0.27% | $2.30B | 0.95% | 21.72% | 0.54 |
| China Meheco Group Co., Ltd. (600056) | 0.26% | $2.30B | -29.98% | 10.06% | 0.67 |
| ACADIA Pharmaceuticals, Inc. (ACAD) | 0.25% | $2.82B | 40.45% | 93.70% | 6.54 |
| SciClone Pharmaceuticals (Holdings) Ltd. (6600) | 0.24% | $1.45B | 9.05% | 74.46% | 1.90 |
| Arvinas, Inc. (ARVN) | 0.23% | $2.24B | -40.26% | 91.46% | 13.01 |
| Galapagos NV (GLPG) | 0.23% | $1.91B | -65.10% | 95.92% | -6.68 |
| Luye Pharma Group Ltd. (2186) | 0.22% | $1.43B | -2.41% | 68.31% | 2.43 |
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (603456) | 0.22% | $2.00B | -16.32% | 33.12% | 2.70 |
| Zai Lab Ltd. (9688) | 0.20% | $1.62B | 24.01% | 64.08% | 6.99 |
| Morphic Holding, Inc. (MORF) | 0.20% | $1.66B | -100.00% | N/A | N/A |
| BioArctic AB (BRCTF) | 0.19% | $1.31B | 169.83% | 56.22% | 36.67 |
| Simulations Plus, Inc. (SLP) | 0.18% | $933.30M | 16.22% | 72.23% | 11.38 |
| MediPharm Labs Corp. (LABS) | 0.03% | $24.96M | 49.49% | 12.75% | 0.24 |
Market data by FactSet